Chih–Yuan Hsu

Also affiliated with Vanderbilt University Medical Center

MedicineMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.310Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Associations of influenza vaccination with severity of immune-related adverse events in patients with advanced thoracic cancers on immune checkpoint inhibitors

ERJ Open Research(2022)10.1183/23120541.00684-2021

Top 65%

0.201DataRank

Top 65%2 citations

Li‐Ching Huang, Jennifer G. Whisenant, Sally J. York, Travis Osterman, Jennifer A. Lewis +7 more

Papers

Driven by 26 papers — median percentile 31. Top paper: “Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study”.

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

The Lancet(2020)10.1016/s0140-6736(20)31187-9

N/A

11.9DataRank · unranked

1804 citations

Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein, Donna R. Rivera +95 more

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

Annals of Oncology(2021)10.1016/j.annonc.2021.02.024

N/A

6.8DataRank · unranked

328 citations

Ali Raza Khaki, Trisha M. Wise‐Draper, Benjamin French, Conor Hennessy, Chih–Yuan Hsu +95 more

COVID-19 vaccination and breakthrough infections in patients with cancer

Annals of Oncology(2021)10.1016/j.annonc.2021.12.006

N/A

3.9DataRank · unranked

102 citations

Chris Labaki, Chih–Yuan Hsu, Ziad Bakouny, Nino Balanchivadze, Stephanie Berg +34 more

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19

JAMA Oncology(2022)10.1001/jamaoncol.2022.5357

N/A

1.5DataRank · unranked

63 citations

Chris Labaki, Punita Grover, Joy Awosika, Shuchi Gulati, Chih–Yuan Hsu +95 more

Analysis of Cancer Survival Associated With Immune Checkpoint Inhibitors After Statistical Adjustment

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.27211

N/A

1.1DataRank · unranked

29 citations

Chih–Yuan Hsu, Lynne D. Berry, Paul A. Bunn, Yu Shyr, Emily Pei-Ying Lin

Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer

JAMA Oncology(2023)10.1001/jamaoncol.2023.5424

N/A

0.911DataRank · unranked

34 citations

Vandana G. Abramson, Elizabeth Claire Dees, Payal D. Shah, Tarah J. Ballinger, Claudine Isaacs +12 more

Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0941

N/A

0.740DataRank · unranked

138 citations

Solange Peters, Orestis A. Panagiotou, Dimpy P. Shah, Nicole M. Kuderer, Chih–Yuan Hsu +40 more

Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium

The Lancet Regional Health - Americas(2023)10.1016/j.lana.2023.100445

N/A

0.553DataRank · unranked

39 citations

Chris Labaki, Ziad Bakouny, Chih–Yuan Hsu, Andrew Schmidt, Gilberto Lopes +39 more

Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer

Cancer Cell(2022)10.1016/j.ccell.2022.04.012

N/A

0.442DataRank · unranked

18 citations

Jorge Gómez, Ananda M. Rodilla, Juan Manuel Carreño, Chih–Yuan Hsu, Christian Rolfo +43 more

Synergistic action of WDR5 and HDM2 inhibitors in SMARCB1-deficient cancer cells

NAR Cancer(2022)10.1093/narcan/zcac007

N/A

0.442DataRank · unranked

18 citations

Chase M. Woodley, Jing Wang, Brian C. Grieb, Macey J. Slota, Kiana Guerrazzi +10 more

Power and sample sizes estimation in clinical trials with treatment switching in intention-to-treat analysis: a simulation study

BMC Medical Research Methodology(2023)10.1186/s12874-023-01864-1

N/A

0.330DataRank · unranked

8 citations

Chih–Yuan Hsu, Yu Shyr, Lejun Deng

Associations of influenza vaccination with severity of immune-related adverse events in patients with advanced thoracic cancers on immune checkpoint inhibitors

ERJ Open Research(2022)10.1183/23120541.00684-2021

Top 65%

0.201DataRank

Top 65%2 citations

Li‐Ching Huang, Jennifer G. Whisenant, Sally J. York, Travis Osterman, Jennifer A. Lewis +7 more

Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)

Lung Cancer(2023)10.1016/j.lungcan.2023.107423

Top 72%

0.109DataRank

Top 72%1 citations

Chih–Yuan Hsu, Jennifer G. Whisenant, Melina E. Marmarelis, Carolyn J. Presley, Karen L. Reckamp +24 more

Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infection

The Lancet Regional Health - Americas(2025)10.1016/j.lana.2025.101038

N/A

0.104DataRank · unranked

1 citations

Chih–Yuan Hsu, Sanjay Mishra, Elizabeth A. Griffiths, Brahm H. Segal, Clara Hwang +30 more

Time-Dependent Effects of Clinical Interventions on SARS-CoV-2 Immunity in Patients with Lung Cancer

Vaccines(2024)10.3390/vaccines12070713

N/A

0.104DataRank · unranked

1 citations

Chih–Yuan Hsu, Ananda M. Rodilla, Jorge Gómez, Jazz Cagan, Yuanhui Huang +19 more

A distribution-free and analytic method for power and sample size calculation in single-cell differential expression

Bioinformatics(2024)10.1093/bioinformatics/btae540

N/A

0.104DataRank · unranked

1 citations

Qi Liu, Yu Shyr, Chih–Yuan Hsu

Microenvironment-aware spatial modeling for accurate inference of cell identity

Nucleic Acids Research(2025)10.1093/nar/gkaf1477

N/A

0DataRank · unranked

0 citations

Yu Wang, Chih–Yuan Hsu, Celestine N. Wanjalla, Ken S Lau, Yu Shyr +1 more

Changing paradigm in oncology clinical trials: Cox-TEL—Adjustment made ready for early crossover and tail tale.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e15067

N/A

0DataRank · unranked

2 citations

Chih–Yuan Hsu, Pan‐Chyr Yang, Yu Shyr, Emily Pei-Ying Lin

Dysregulated ligand–receptor interactions from single-cell transcriptomics

Bioinformatics(2022)10.1093/bioinformatics/btac294

N/A

0DataRank · unranked

20 citations

Chih–Yuan Hsu, Jia Li, Yu Shyr, Qi Liu

Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors: Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival Benefit

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.08.010

N/A

0DataRank · unranked

1 citations

Chih–Yuan Hsu, Jeng-Fong Chiou, Lynne D. Berry, Leora Horn, Paul A. Bunn +5 more

Scalable and model-free detection of spatial patterns and colocalization

Genome Research(2022)10.1101/gr.276851.122

N/A

0DataRank · unranked

61 citations

Chih–Yuan Hsu, Yu Shyr, Qi Liu

Power and sample sizes estimation in clinical trials with treatment switching in intention-to-treat analysis: a simulation study

medRxiv(2022)10.1101/2022.09.07.22279686

N/A

0DataRank · unranked

0 citations

Chih–Yuan Hsu, Yu Shyr, Lejun Deng

scKWARN: Kernel-weighted-average robust normalization for single-cell RNA-seq data

Bioinformatics(2024)10.1093/bioinformatics/btae008

N/A

0DataRank · unranked

2 citations

Chih‐Han Chang, Qi Liu, Yu Shyr, Chih–Yuan Hsu

VICTOR: Validation and inspection of cell type annotation through optimal regression

Computational and Structural Biotechnology Journal(2024)10.1016/j.csbj.2024.08.028

N/A

0DataRank · unranked

0 citations

Chih–Yuan Hsu, Qi Liu, Yu Shyr, Chia-Jung Chang

Power and sample size calculation for non-inferiority trials with treatment switching in intention-to-treat analysis comparing RMSTs

Research Square(2024)10.21203/rs.3.rs-5418253/v1

N/A

0DataRank · unranked

0 citations

Chih–Yuan Hsu, Yu Shyr, Austin Shih

Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium

UNC Libraries(2025)10.17615/bna9-v350

N/A

0DataRank · unranked

0 citations

Sanjay Mishra, Karen Russell, Samuel M. Rubinstein, Blau, Sibel, Daniel Y. Reuben +39 more

Chih–Yuan Hsu

Indexed papers

Top data-sharing exemplar

Papers